Dr. Yang Yuanping, a domestic medical expert, pointed out that compared with previous hypoglycemic products, “hypoglycemic polypeptide” technology has four advantages: 1.
Two, protect the islet;
Three, high safety;

4. Good synergy.
   Concretely reflected in the following aspects: First

Activates “inert” insulin and lowers blood sugar.
Part of the patient’s insulin has structural defects, insulin activity loss, can not play a role normally, known as the “inert” insulin.
“Hypoglycemic polypeptide” can activate “inert” insulin, recover its activity, normally participate in glucose metabolism, improve the human body’s own ability to use and transform blood glucose, and steadily reduce blood glucose.

The second

Protect islet cells and inhibit islet failure.
The increase of insulin that can participate in sugar metabolism, the islet does not have to secrete too much insulin as before, the burden of islet is reduced, the islet can get necessary rest, and then play the role of protecting the islet and inhibiting the failure of the islet.
The third

Reduce chemical dependence.
The islet is recuperated, the function of the existing islet is gradually recovered, and its ability to regulate blood sugar is enhanced, thus reducing the dependence of human body on drugs accordingly. On this basis, patients can reduce the dosage and variety of chemical drugs to reduce the damage of drugs to the body.
The fourth

Correct the three metabolic disorders, prevent the generation of complications.
The improvement of the conversion and utilization ability of blood sugar can not only effectively improve the disorder of glucose metabolism, but also play a positive role in regulating the disorder of fat and protein metabolism.
Patients only need to properly control their diet, which is not only conducive to the supplement of daily nutrition, but also can enhance the patient’s constitution, delaying and reducing the occurrence of complications.